20例伊朗先天性遗传性内皮营养不良先证者中9个已报道和10个未报道SLC4A11突变的观察,以及一个家系中MPDZ突变可能为CHED与FECD病因的鉴定
该研究对21例伊朗CHED患者行SLC4A11测序,在20例中检出9个已报道和10个未报道突变,1例未检出;该例经外显子测序发现MPDZ突变为唯一候选病因,其携带同一突变的母亲被诊断为FECD。作者认为SLC4A11突变是伊朗人CHED的常见病因,MPDZ突变可能在少数患者中导致CHED乃至FECD。
要点
- 20例CHED患者检出SLC4A11突变,其中9个已报道、10个未报道,1例未检出。
- 10个新突变使该基因发现作用十余年来报道的约85个突变显著增加。
- 1例无SLC4A11突变患者检出MPDZ突变,其携带同一突变的母亲诊断为FECD。
核心结论
- SLC4A11突变是伊朗人CHED的常见病因。
- 观察到的10个新突变对自该基因在CHED发病中的作用被发现十余年来报道的约85个突变有显著贡献。
- MPDZ突变可能在少数患者中为CHED乃至FECD的病因。
- MPDZ在紧密连接和维持角膜内皮屏障方面提出的功能与角膜内皮病理生物学中的作用相符。
研究设计与样本
- 对21例伊朗CHED患者行SLC4A11测序筛查。
- 对先前未报道的变异在至少200名对照中核查,并进行家系内共分离分析和生物信息学预测。
- 对1例无SLC4A11突变的患者及其父母行外显子测序。
主要发现
- 20例患者中观察到9个已报道和10个未报道的SLC4A11突变,1例患者未发现突变。
- 该无SLC4A11突变患者中鉴定出MPDZ突变为CHED的唯一候选病因。
- 其携带同一突变的母亲被诊断为Fuchs内皮性角膜营养不良(FECD)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: SLC4A11 is the only known causative gene of congenital hereditary endothelial dystrophy (CHED). Mutation screenings have shown that most but not all patients with CHED harbour mutations in SLC4A11, suggesting that other CHED-causing genes may exist. We aimed to screen SLC4A11 in Iranian patients to learn the mutation spectrum of this gene among Iranians and to gain further knowledge on potential contribution of other genes to CHED aetiology. METHODS: SLC4A11 was screened in 21 Iranian patients with CHED by sequencing. Previously unreported variations were checked in at least 200 controls, and segregation analysis within families and bioinformatics predictions on effects of variations were performed. Exome sequencing was done for the single patient without an SLC4A11 mutation and for her parents. RESULTS: Nine previously reported and 10 unreported SLC4A11 mutations were observed among 20 patients; a mutation was not found in one patient. A mutation in MPDZ was identified as the only candidate cause of CHED in this patient. Her mother who carried the same mutation was diagnosed with Fuchs endothelial corneal dystrophy (FECD). CONCLUSION: SLC4A11 mutations are the usual cause of CHED in Iranians. The 10 novel mutations observed contribute significantly to the approximately 85 mutations reported since discovery of the role of the gene in CHED pathogenesis more than 10 years ago. MPDZ mutations may be a cause of CHED and even FECD in a minority of patients. Proposed functions of MPDZ with respect to tight junctions and maintenance of the corneal endothelial barrier are in accordance with a role in corneal endothelial pathobiology.
引用
- Moazzeni H, Javadi MA, Asgari D, et al. Observation of nine previously reported and 10 non-reported SLC4A11 mutations among 20 Iranian CHED probands and identification of an MPDZ mutation as possible cause of CHED and FECD in one family. Br J Ophthalmol. 2019. PMID: 31420327. doi:10.1136/bjophthalmol-2019-314377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。